China Holdings, Inc. - Notification that Annual Report will be submitted late (NT 10-K)
02 April 2008 - 4:26AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington,
D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE
FILING
(Check
One):
|
x
Form
10-KSB
|
o
Form
20-F
|
o
Form
11-K
|
o
Form
10-D
|
|
|
|
|
|
|
o
Form
10-QSB
|
o
Form
N-SAR
|
o
Form
N-CSR
|
|
For
Period Ended:
December 31,
2007
|
|
o
Transition
Report on Form 10-K
|
|
|
|
|
¨
Transition Report
on Form 20-F
|
|
|
|
|
o
Transition
Report on Form 11-K
|
|
|
|
|
o
Transition
Report on Form 10-Q
|
|
|
|
|
o
Transition
Report on Form N-SAR
|
|
|
For the Transition Period Ended:
|
Read Instruction (on back
page) Before Preparing Form. Please Print or
Type.
Nothing in this form shall be
construed to imply that the Commission has verified any information
contained herein.
|
If the
notification relates to a portion of the filing checked above, identify the
item(s) to which the notification relates:
___________________________________________________________________________________________________
PART I - REGISTRANT
INFORMATION
CHINA HOLDINGS,
INC
Full name
of Registrant
CHINA HEALTH HOLDINGS,
INC.
Former
Name if Applicable
101 Convention Center Drive,
Suite 700
Address
of Principal Executive Office
(Street and
Number)
Las Vegas, NV
89107-2001
City,
State and Zip Code
PART II - RULE 12b-25(b) AND
(c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate.)
|
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could not
be eliminated without
unreasonable
effort or expense;
|
|
x
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K,
Form 20-F, Form 11-K, Form N-SAR, or Form N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report or transition report
on
Form 10-Q, or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date;
and
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if
applicable.
|
PART III -
NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D,
N-SAR, N-CSR, or the transition report or portion thereof, could not be filed
within the prescribed time period.
(Attach
extra sheets if needed.)
The
compilation, dissemination and review of the information required to be
presented in the Form 10-QSB for the relevant period has imposed time
constraints that have rendered timely filing of the Form 10-QSB impracticable
without undue hardship and expense to the registrant. The registrant
undertakes the responsibility to file such report no later than five days after
its original prescribed due date.
PART
IV - OTHER INFORMATION
|
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
|
Julianna
Lu
|
86-10-6586-4790
|
|
(Name)
|
(Telephone
Number)
|
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s). Yes
x
No
¨
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
|
Yes
¨
No
x
If so:
attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
CHINA HEALTH HOLDING,
INC.
(Name
of Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the undersigned thereunto
duly authorized.
|
|
|
|
|
|
|
|
|
|
Date:
March 31,
2008
|
By:
|
/s/ Julianna Lu
|
|
|
|
|
Name Julianna Lu
|
|
|
|
|
Title Chief Executive
Officer
|
|
|
|
|
|
|
INSTRUCTION:
The form may be signed by an executive officer of the registrant or by any other
duly authorized representative. The name and title of the person signing the
form shall be typed or printed beneath the signature. If the statement is signed
on behalf of the registrant by an authorized representative (other than an
executive officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
China (CE) (USOTC:CHHL)
Historical Stock Chart
From Jan 2025 to Feb 2025
China (CE) (USOTC:CHHL)
Historical Stock Chart
From Feb 2024 to Feb 2025
